Your National Launch Plan is Failing Against the Payer Gatekeepers of Dallas Pharma.
Your molecule achieved its endpoints, the FDA gave you the green light, and your national commercialization strategy is backed by millions. Yet, in the nation’s fastest-growing market, your uptake is flatlining. Why? Because your strategy wasn’t built for the fiercely independent provider networks and unique payer mix of Texas. Here, securing formulary access and influencing prescribing habits requires a completely different playbook—one that national models simply can’t predict. Don’t let your blockbuster asset fail in its most critical market. M.I.I. connects you with the commercial VPs and market access gurus who have successfully launched multi-billion dollar drugs specifically within the Dallas-Fort Worth ecosystem. They deliver the insider tactics to win over Texas’s powerful GPOs and KOLs, ensuring your breakthrough therapy achieves the market penetration it deserves.
